2020 Chronic GVHD Conference

Starts:  Nov 18, 2020 9:00 AM (CT)
Ends:  Nov 20, 2020 5:00 PM (CT)

Due to the Covid-19 crisis the 2020, 3rd NIH Chronic GvHD Consensus Conference will be held as a virtual meeting over 3 days through six 2-hour sessions on Wednesday-Friday November 18-20. The main goal of the conference is to review progress on key documents which four working groups have been preparing since November 2019 initial planning meeting.  The main objective is to “think out of box” and determine gaps and what should be done to advance field of chronic GvHD and allogeneic transplantation within next 3-7 years. Submission of these papers for publication is planned through February – June 2021. While nothing can supplement the in-person meeting interactions this year virtual format, on the other hand it will allow much broader live participation of all interested stakeholders nationally and internationally who will be able to register and actively participate in this scientific event. 


Sessions Include:

  • Etiology & prevention of chronic GvHD
  • Diagnosis & pre-emptive treatment of chronic GvHD
  • Treatment of established chronic GvHD
  • Highly morbid forms of chronic GvHD
  • Industry summit
  • Patient/Advocacy Summit


Steering Committee:  Steven Pavletic, Stephanie Lee, Kirk Schultz, Daniel Wolff, Hildegard Greinix, Sophie Paczesny, Bruce Blazar, Stefanie Sarantopoulos, Joseph Pidala, Corey Cutler, Gerard Socie, Paul Martin, Meredith Cowden.


Online Instructions:
Url: http://astct.org